[{"id":"46612199-ef89-461b-ba2d-66518055f785","acronym":"","url":"https://clinicaltrials.gov/study/NCT05985161","created_at":"2023-08-14T16:10:05.963Z","updated_at":"2025-02-25T16:40:04.331Z","phase":"Phase 2","brief_title":"A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors","source_id_and_acronym":"NCT05985161","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" XPO1","pipe":" | ","alterations":" XPO1 E571K • XPO1 mutation","tags":["XPO1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e XPO1 E571K • XPO1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xpovio (selinexor)"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 08/01/2029","primary_completion_date":" 08/01/2029","study_txt":" Completion: 08/01/2029","study_completion_date":" 08/01/2029","last_update_posted":"2025-02-06"}]